HSPG2 and neoplasm: Examples include NPs with GPC-3 antibodies, which are abundant in PLC [154], and platelet-loaded levantinib/sorafenib that adheres to tumor blood vessels and tumor-circulating cells, therefore increasing accumulation at those sites [5,194].